首页> Diabetes, obesity & metabolism.> Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes

Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes

导出原文传递

翻译打印收藏纠错

第一作者： Thomas Klein

作者： Thomas Klein ^[1]

作者单位： Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelhein, Germany ^[1]

关键词 albuminuria diabetic nephropathy DPP-4 inhibitor linagliptin treatment response prediction urinary DPP-4 protein

发布时间 2021-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes, obesity & metabolism.

2021年23卷8期

1968-1972页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Diabetes, obesity & metabolism.

2021年23卷8期

1968-1972页

检索历史清除

Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes

Diabetes, obesity & metabolism.

相似文献

同项目论文

Diabetes, obesity & metabolism.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes

Diabetes, obesity & metabolism.

相似文献

同项目论文

Diabetes, obesity & metabolism.

相关期刊

检索历史清除